W

Hims & Hers struck a GLP-1 deal with Lilly. Its stock is rallying.

Business Management
Share
Hims & Hers struck a GLP-1 deal with Lilly. Its stock is rallying.

As part of the agreement, Hims said it won’t compound GLP-1 medications like Zepbound in the future.

Hims & Hers struck a GLP-1 deal with Lilly. Its stock is rallying.

Source：MarketWatch

Disclaimer：Please read market information rationally and stay aware of investment risks. All content on this site is for informational purposes only and does not constitute investment advice.

Related Reading

Nvidia may face a more hostile post-election Washington: Report

CEO Jensen Huang’s relationship with President Donald Trump probably won’t save the company from a more adversarial Washington, Semafor says.…

Elon Musk opens the door for a big SpaceX acquisition

The rocket and satelliteinternet company is looking to challenge telecom giants. Source：MarketWatch

Data centers run on debt. That was a problem for bonds this year — and it’s only going to get worse.

AI debt issuance this year overwhelmed investor portfolios, and has disappointed from a performance perspective. The funding need won’t get any better with…

US Treasury cuts off MEXC over alleged $16B in illicit transactions

The US Treasury bureau FinCEN on Friday ordered US financial institutions to stop processing transfers involving MEXC Global. Source：Cointelegraph

Source：https://www.marketwatch.com/story/hims-hers-struck-a-glp-1-deal-with-lilly-its-stock-is-rallying-d06ebe60